Evidence map›Paper›PMID 25195643›Full record

ArticleEpidemiology and infection2015

Stakeholder prioritization of zoonoses in Japan with analytic hierarchy process method.

M Kadohira, G Hill, R Yoshizaki, S Ota, Y Yoshikawa

Abstract read
In one paragraph

Article in Epidemiology and infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Zoonotic pathogens and diseases detected in Vietnam, 2020-2021.One health (Amsterdam, Netherlands) · 2022
    Article
  11. Article
  12. Article
  13. A Risk Analysis Framework for Prioritizing and Managing Biosecurity Threats.Risk analysis : an official publication of the Society for Risk Analysis · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M KadohiraObihiro University of Agriculture and Veterinary Medicine,Obihiro,Japan.
G HillObihiro University of Agriculture and Veterinary Medicine,Obihiro,Japan.
R YoshizakiToray Research Center,Tokyo,Japan.
S OtaJapan Fresh Produce Import and Safety Association,Tokyo,Japan.
Y YoshikawaChiba Institute of Science,Chiba,Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There exists an urgent need to develop iterative risk assessment strategies of zoonotic diseases. The aim of this study is to develop a method of prioritizing 98 zoonoses derived from animal pathogens in Japan and to involve four major groups of stakeholders: researchers, physicians, public health officials, and citizens. We used a combination of risk profiling and analytic hierarchy process (AHP). Profiling risk was accomplished with semi-quantitative analysis of existing public health data. AHP data collection was performed by administering questionnaires to the four stakeholder groups. Results showed that researchers and public health officials focused on case fatality as the chief important factor, while physicians and citizens placed more weight on diagnosis and prevention, respectively. Most of the six top-ranked diseases were similar among all stakeholders. Transmissible spongiform encephalopathy, severe acute respiratory syndrome, and Ebola fever were ranked first, second, and third, respectively.

Indexed as

Data Interpretation, StatisticalHealth PrioritiesAnimalsFemaleHemorrhagic Fever, EbolaHumansIncidenceJapanMalePrion DiseasesPublic HealthRisk AssessmentSevere Acute Respiratory SyndromeSurveys and QuestionnairesZoonoseszoonoses

Identifiers

PMID25195643
PMCPMC9507200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.